Laura Murphy1, Alastair Gray1, Emer Joyce2,3. 1. Department of Cardiology, Mater Misericoridiae University Hospital, Dublin, Ireland. 2. Department of Cardiology, Mater Misericoridiae University Hospital, Dublin, Ireland. emerjoyce@mater.ie. 3. Heart Failure and Cardiac Transplantation, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland. emerjoyce@mater.ie.
Abstract
PURPOSE OF REVIEW: Malnutrition, sarcopenia, and cachexia are areas of increasing interest in the management of patients with heart failure (HF). This review aims to examine the serological markers useful in guiding the physician in identification of these patients. RECENT FINDINGS: Traditional nutritional biomarkers including albumin/prealbumin, iron, and vitamin D deficiencies predict poor prognosis in malnutrition and HF. Novel biomarkers including ghrelin, myostatin, C-terminal agrin fragment, and adiponectin have been identified as possible substrates and/or therapeutic targets in cardiac patients with sarcopenia and cachexia, though clinical trial data is limited to date. Increased focus on nutritional deficiency syndromes in heart failure has led to the use of established markers of malnutrition as well as the identification of novel biomarkers in the management of these patients, though to date, their usage has been confined to the academic domain and further research is required to establish their role in the clinical setting.
PURPOSE OF REVIEW: Malnutrition, sarcopenia, and cachexia are areas of increasing interest in the management of patients with heart failure (HF). This review aims to examine the serological markers useful in guiding the physician in identification of these patients. RECENT FINDINGS: Traditional nutritional biomarkers including albumin/prealbumin, iron, and vitamin D deficiencies predict poor prognosis in malnutrition and HF. Novel biomarkers including ghrelin, myostatin, C-terminal agrin fragment, and adiponectin have been identified as possible substrates and/or therapeutic targets in cardiac patients with sarcopenia and cachexia, though clinical trial data is limited to date. Increased focus on nutritional deficiency syndromes in heart failure has led to the use of established markers of malnutrition as well as the identification of novel biomarkers in the management of these patients, though to date, their usage has been confined to the academic domain and further research is required to establish their role in the clinical setting.
Authors: S D Anker; M Volterrani; C D Pflaum; C J Strasburger; K J Osterziel; W Doehner; M B Ranke; P A Poole-Wilson; A Giustina; R Dietz; A J Coats Journal: J Am Coll Cardiol Date: 2001-08 Impact factor: 24.094
Authors: T Cederholm; I Bosaeus; R Barazzoni; J Bauer; A Van Gossum; S Klek; M Muscaritoli; I Nyulasi; J Ockenga; S M Schneider; M A E de van der Schueren; P Singer Journal: Clin Nutr Date: 2015-03-09 Impact factor: 7.324
Authors: Michael G Shlipak; Catherine Stehman-Breen; Linda F Fried; Xiao Song; David Siscovick; Linda P Fried; Bruce M Psaty; Anne B Newman Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860
Authors: Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker Journal: Eur Heart J Date: 2014-08-31 Impact factor: 29.983
Authors: Jerneja Farkas; Stephan von Haehling; Kamyar Kalantar-Zadeh; John E Morley; Stefan D Anker; Mitja Lainscak Journal: J Cachexia Sarcopenia Muscle Date: 2013-03-29 Impact factor: 12.910
Authors: Marta Kałużna-Oleksy; Helena Krysztofiak; Jacek Migaj; Marta Wleklik; Magdalena Dudek; Izabella Uchmanowicz; Maciej Lesiak; Ewa Straburzyńska-Migaj Journal: Nutrients Date: 2020-08-04 Impact factor: 5.717
Authors: María Elena Soto; Israel Pérez-Torres; María Esther Rubio-Ruiz; Linaloe Manzano-Pech; Verónica Guarner-Lans Journal: Cells Date: 2022-03-18 Impact factor: 6.600